Conclusion The expression of cathepsin D in cancer cells can be used to evaluate the lymph node metastaticpredilection and poor prognosis in NSCLC.

• 结论组织蛋白酶D可作为判断非小细胞肺癌淋巴结转移潜能和预后的辅助标志。